Element Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 449

Employees

  • Latest Deal Type
  • Series E

  • Investors
  • 15

Element Biosciences General Information

Description

Developer of genetic analysis tools designed to be used for the research and diagnostic markets. The company's technology develops a modular and high-performing DNA sequencing platform that will deliver quality data and workflow flexibility and make next-generation sequencing technology more accessible, enabling medical researchers to benefit from and improve their research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10055 Barnes Canyon Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (619)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 10055 Barnes Canyon Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (619)

Element Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Element Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 09-Jun-2026 Completed Generating Revenue
6. Later Stage VC (Series D) 11-Jul-2024 Completed Generating Revenue
5. Accelerator/Incubator 23-Mar-2023 Completed Generating Revenue
4. Later Stage VC (Series C) 29-Jun-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 26-Jun-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Jun-2019 $15M $20M Completed Stealth
1. Seed Round 11-Sep-2017 $5M $5M Completed Stealth
To view Element Biosciences’s complete valuation and funding history, request access »

Element Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series D-1
Series C
Series B
Series A 8,299,215 $0.000100 $0.11 $1.81 $1.81 1x $1.81 6.23%
Seed 8,865,115 $0.000100 $0.03 $0.58 $0.58 1x $0.58 6.66%
To view Element Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Element Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genetic analysis tools designed to be used for the research and diagnostic markets. The company's technolog
Diagnostic Equipment
San Diego, CA
449 As of 2026

Bangalore, India

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Element Biosciences Competitors (27)

One of Element Biosciences’s 27 competitors is InterpretOmics, a Formerly VC-backed company based in Bangalore, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InterpretOmics Formerly VC-backed Bangalore, India
DNAnexus Venture Capital-Backed San Francisco, CA
Qlucore Formerly VC-backed Lund, Sweden
Illumina Formerly VC-backed San Diego, CA
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
You’re viewing 5 of 27 competitors. Get the full list »

Element Biosciences Patents

Element Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026217901-A1 Compositions for fluorescence resonance energy transfer in high throughput sequencing Pending 11-Apr-2025
WO-2026207503-A1 Sequencing systems Pending 27-Mar-2025
WO-2026198648-A2 Cell-based display polypeptides and methods of use thereof Pending 18-Mar-2025
WO-2026198648-A3 Cell-based display polypeptides and methods of use thereof Pending 18-Mar-2025
WO-2026192958-A1 Base calling in next generation sequencing analysis Pending 10-Mar-2025 G06V20/693
To view Element Biosciences’s complete patent history, request access »

Element Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Element Biosciences Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Samsung Electronics Corporation Minority
Wellington Management Asset Manager Minority
CONNECT (San Diego) Accelerator/Incubator
Counterpoint Global Asset Manager Minority
Janus Henderson Investors Asset Manager Minority
You’re viewing 5 of 15 investors. Get the full list »

Element Biosciences Acquisitions (1)

Element Biosciences’s most recent deal was a Merger/Acquisition with Loop Genomics. The deal was made on 08-Feb-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Loop Genomics 08-Feb-2022 Merger/Acquisition Medical Supplies
To view Element Biosciences’s complete acquisitions history, request access »

Element Biosciences FAQs

  • When was Element Biosciences founded?

    Element Biosciences was founded in 2017.

  • Where is Element Biosciences headquartered?

    Element Biosciences is headquartered in San Diego, CA.

  • What is the size of Element Biosciences?

    Element Biosciences has 449 total employees.

  • What industry is Element Biosciences in?

    Element Biosciences’s primary industry is Diagnostic Equipment.

  • Is Element Biosciences a private or public company?

    Element Biosciences is a Private company.

  • What is Element Biosciences’s current revenue?

    The current revenue for Element Biosciences is .

  • How much funding has Element Biosciences raised over time?

    Element Biosciences has raised $683M.

  • Who are Element Biosciences’s investors?

    Samsung Electronics, Wellington Management, CONNECT (San Diego), Counterpoint Global, and Janus Henderson Investors are 5 of 15 investors who have invested in Element Biosciences.

  • Who are Element Biosciences’s competitors?

    InterpretOmics, DNAnexus, Qlucore, Illumina, and Oxford Nanopore Technologies are some of the 27 competitors of Element Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process